this protocol describes the use of sortase-mediated reactions to label the n terminus of any given protein of interest. the sortase recognition sequence, lpXtG (for Staphylococcus aureus sortase a) or lpXta (for Streptococcus pyogenes sortase a), can be appended to a variety of probes such as fluorophores, biotin or even to other proteins. the protein to be labeled acts as a nucleophile by attacking the intermediate formed between the probe containing the lpXtG/a motif and the sortase enzyme. If sortase, the protein of interest and a suitably functionalized label are available, the reactions usually require less than 3 h. after the initial methionine, which is often removed by methionylaminopeptidase 40 . The requisite number of glycines/ alanines should be determined empirically, as it depends on the exposure of the N terminus, although usually three residues suffice. A linker may be interposed between the N-terminal glycines/alanines and the remainder of the protein to improve accessibility 10 . Either sortase A from S. aureus or S. pyogenes can be used for labeling with comparable efficiency. A mutated strain of S. aureus that does not require Ca 2 + also exists and can be used when precipitation occurs owing to the presence of Ca 2 + (ref. 23). The S. pyogenes and Ca 2 + -dependent S.aureus sortases A are most commonly used because they are expressed in higher yields than the Ca 2 + -independent sortase A. When the initial methionine is not (completely) removed after protein synthesis, we use an alternative strategy to expose glycine residues at the N terminus: a thrombin cleavage site (Leu-Val-Pro-Arg-Gly) is inserted to precede the glycine stretch 39, 41 . Thrombin cleaves between the arginine and glycine residues, thus ensuring that upon cleavage these glycines are exposed on the protein molecule to be labeled. Although thrombin is somewhat specific, we recommend that before choosing this option the user should confirm that the protein of interest is not itself directly susceptible to thrombin cleavage. Alternative proteases such as tobacco etch virus (TEV) and factor XA may also be used, as they can cleave the protein to allow for an N-terminal glycine. To date, we have yet to find a protein that does not become labeled as long as the N terminus is adequately exposed.
IntroDuctIon
Modification of proteins with fluorophores or other compounds of interest enables the creation of novel biological tools to study cellular pathways and molecular mechanisms [1] [2] [3] [4] . Conjugation of a toxic moiety or antigen to a targeting antibody expands the use of these proteins for cellular delivery purposes, while reducing toxic side effects [5] [6] [7] . The key to tagging the protein of interest without disrupting its structure or function is selective sitespecific labeling. Specific labeling at the N terminus of a protein is often the only option available, either because of the constraints imposed by the protein's topology [8] [9] [10] or because the native C terminus is essential for function (e.g., ubiquitin) 11, 12 and/or cellular membrane anchoring 13, 14 , which renders cytosolic portions of proteins inaccessible to added sortase if labeling is to be conducted on intact cells.
Maleimide and N-hydroxysuccinimide (NHS) ester-derived probes are commonly used to modify proteins, as they are reactive with thiol and amino groups of cysteine and lysine, respectively [15] [16] [17] . Although cysteines and lysines can be introduced at the N terminus of a protein, the use of side chain-reactive probes lacks selectivity and may also compromise the active site of the protein being labeled. Genetic engineering approaches allow sitespecific modification, but they may interfere with the protein structure 18, 19 . Mutations can cause protein misfolding and/or aggregation 20 , or they can preclude the assembly of active protein complexes 1 . Many diseases are the result of naturally occurring mutations, such as those found in the cystic fibrosis transmembrane conductance receptor 21 , which illustrate the issues that can occur with misfolded proteins. Selective labeling with ketone-oxime chemistry has also enabled efficient labeling of the N terminus of proteins, but the reaction times are slightly long 22 . The sortase-mediated labeling method described here overcomes many of these challenges 23 , but the possibility of unintended alterations that interfere with protein function should always be considered in design and interpretation.
Sortases are expressed by Gram-positive bacteria. They are essential in cell wall biosynthesis [24] [25] [26] [27] and covalent attachment of proteins to the peptidoglycan cell wall. Additional background on sortase enzymes and a detailed protocol for C-terminal labeling using sortases can be found in Guimaraes et al. 23 . In the specific instance of N-terminal labeling described here, the protein to be labeled is engineered with an exposed stretch of glycines or alanines at its N terminus when using sortase A from S. aureus or S. pyogenes, respectively. A peptide decorated with a functional group of choice (fluorophores, biotin, lipids, nucleic acids, carbohydrates and so on) and comprising a sortase recognition motif LPXTG/A sequence (X being any amino acid [28] [29] [30] [31] [32] [33] [34] [35] ) at its C terminus is then added to the reaction together with sortase. Sortase A cleaves between the threonine and glycine/alanine residues, forming a thioester intermediate with the peptide probe. Nucleophilic attack by the N-terminally modified protein of interest resolves the intermediate, resulting in the formation of a covalent bond between the peptide probe and the N terminus of the protein (Fig. 1) .
Alternatively, depsi-peptides can be used for N-terminal labeling 35, 36 . Depsi-peptides feature an ester linkage between the threonine and glycine, instead of an amide peptide bond to yield a more effective leaving group. By using depsi-peptides, the probe concentration in the reaction can be lowered while maintaining high yields. N-terminal sortase labeling can also be used to make unique N-to-N-terminally linked chimeric proteins, with two free C-terminal residues, the detailed information of which can be found in a separate protocol 37 . These chimeric structures allow for the study of interactions or associations of two proteins, in which both C termini are essential for function 38 . It should also be noted that C-to-C-terminally linked proteins can also be formed. Overall, sortase-mediated reactions provide a high level of selectivity for N-terminal labeling and can provide a labeled protein product in high yield (>90%) and good purity.
Experimental design
Engineering the protein of interest. Proteins to be labeled at the N terminus must display glycine (sortase A, S. aureus) or alanine (sortase A, S. pyogenes) residues at their N terminus 10, 29, 35, 39 . By using standard molecular cloning methods, a stretch of one to five glycines or two to five alanines is introduced immediately Site-specific N-terminal labeling of proteins using sortase-mediated reactions after the initial methionine, which is often removed by methionylaminopeptidase 40 . The requisite number of glycines/ alanines should be determined empirically, as it depends on the exposure of the N terminus, although usually three residues suffice. A linker may be interposed between the N-terminal glycines/alanines and the remainder of the protein to improve accessibility 10 . Either sortase A from S. aureus or S. pyogenes can be used for labeling with comparable efficiency. A mutated strain of S. aureus that does not require Ca 2 + also exists and can be used when precipitation occurs owing to the presence of Ca 2 + (ref. 23 ). The S. pyogenes and Ca 2 + -dependent S.aureus sortases A are most commonly used because they are expressed in higher yields than the Ca 2 + -independent sortase A. When the initial methionine is not (completely) removed after protein synthesis, we use an alternative strategy to expose glycine residues at the N terminus: a thrombin cleavage site (Leu-Val-Pro-Arg-Gly) is inserted to precede the glycine stretch 39, 41 . Thrombin cleaves between the arginine and glycine residues, thus ensuring that upon cleavage these glycines are exposed on the protein molecule to be labeled. Although thrombin is somewhat specific, we recommend that before choosing this option the user should confirm that the protein of interest is not itself directly susceptible to thrombin cleavage. Alternative proteases such as tobacco etch virus (TEV) and factor XA may also be used, as they can cleave the protein to allow for an N-terminal glycine. To date, we have yet to find a protein that does not become labeled as long as the N terminus is adequately exposed.
Synthesis of LPXTG/A-containing peptides. Many core facilities devoted to peptide synthesis can deliver modified peptides for use in N-terminal sortase-catalyzed labeling. Alternatively, commercial providers are a readily accessible source of these materials. However, manual synthesis is cost effective, and it expands the range of modifications possible for the individual user; for these reasons it is included in this protocol. The following section provides a protocol for the synthesis of 5(6)-TAMRA-linked, biotinlinked and NHS ester-linked probes for sortase A-mediated reactions. Attachment of fluorophores allows microscopy of internalized labeled proteins, whereas biotin attachment is especially useful for tagging proteins for pull-down experiments with streptavidin beads. For N-terminal reactions, the functional group is introduced at the N terminus of a LPETGG peptide for S. aureus and a LPETAA peptide for S. pyogenes sortase A. Although any amino acid can be placed between the proline and the threonine, we prefer glutamic acid or other polar amino acids to aid in the precipitation of crude peptide after cleavage from the solid-phase resin. To reduce the time required for synthesis and purification, Fmoc-Lys(biotin)-OH, Fmoc-Lys(5-TAMRA)-OH and other preconjugated building blocks can be obtained commercially. These building blocks should be coupled to the leucine residue of the sortase recognition sequence.
It is important to note that the sortase recognition motif is LPXTG; at least one additional amino acid is required at the C terminus to allow sortase to properly bind. We opt for an additional glycine (LPXTGG), but any amino acid may be used. 
MaterIals

REAGENTS
! cautIon For all items marked with a Caution callout, please use proper personal protective equipment (gloves, eye protection and proper attire).
The use of these chemicals should be carried out in a fume hood when possible. For more information, please refer to each item's MSDS. Purified sortase A in buffer (no phosphate-based buffer if a Ca 2 + -dependent sortase A is used). Detailed expression and purification of the various sortase A enzymes, as well as the reagents involved, can be found in Guimaraes et al. 23 Protein to be labeled containing a stretch of 1-5 glycine (S. aureus) or 2-5 alanine (S. pyogenes) residues at the N terminus in a pH 6-8 buffer.
A 3-aa terminus is most commonly used. 
• proceDure synthesis of lpetG/a-containing peptides 1| There are three options for synthesizing the peptides. Option A describes the synthesis of the TAMRA-LPETGG probe, option B describes the synthesis of the biotin-LPETGG probe, and option C describes the addition of other functional groups or acid-labile substituents to the LPETGG motif using NHS ester couplings. In all steps, NMP may be replaced with DMF.
(a) taMra-lpetGG probe • tIMInG 30 h (2.5-3 h between each pause point)  crItIcal step Use Fmoc-Ala-OH in place of Fmoc-Gly-OH to make probes for S. pyogenes sortase A.
(i) Resin preparation. Add 100 µmol of Rink amide resin (167 mg, 0.6 mmol g − 1 ) into a capped glass column with a fritted glass filter bottom, solvate the resin in DCM (7 ml) by shaking it for 15 min in a Wrist-Action shaker and remove the DCM by vacuum filtration. (ii) Deprotection. Add 20% (vol/vol) piperidine solution in NMP (7 ml) and shake it for 15 min to remove the resin's Fmoc-protecting groups. (iii) Remove the piperidine solution by vacuum filtration and wash the resin three times with NMP (7 ml, 1 min), three times with DCM (7 ml, 1 min) and an additional time with NMP (1 min).
(iv) Coupling reaction. Dissolve Fmoc-Gly-OH (89 mg, 300 µmol), HBTU (114 mg, 300 µmol) and DIPEA (104 µl, 600 µmol) in NMP (7 ml) and add the solution to the resin. Shake the suspension for 2 h at room temperature. (v) Remove the reaction solution by vacuum filtration and wash the resin three times with NMP (7 ml, 1 min) and three times with DCM (7 ml, 1 min).  crItIcal step At this stage, store the peptides in their Fmoc-protected form.  pause poInt The resin can be stored at 4 °C after drying it under vacuum. (vi) Confirm the coupling reaction by performing a Kaiser test. Detailed information on the reagents and setup for the Kaiser test can be found in Box 1 of the C-terminal sortase labeling protocol 23 .  crItIcal step If the reaction is incomplete, repeat Step 1A(iv, v) with half the amount of reagents used for a standard coupling; shake it for 1 h. (vii) Repeat Step 1A(i-vi) with Fmoc-Gly-OH (89 mg, 300 µmol), Fmoc-Thr(OtBu)-OH (119 mg, 300 µmol), Fmoc-Glu(OtBu)-OH (127 mg, 300 µmol), Fmoc-Pro-OH (101 mg, 300 µmol), Fmoc-Leu-OH (106 mg, 300 µmol) and Fmoc-ε-aminocaproic acid (85 mg, 300 µmol).  crItIcal step The Kaiser test does not work for verifying the extent of the leucine coupling, as the N terminus of proline is a secondary amine. To test this coupling reaction, one can use the chloranil test or microcleavage assay (the microcleavage assay can be found at http://www.nature.com/nprot/journal/v8/n9/box/nprot.2013.101_BX1. html) 23, 42, 43 . Note that the orthogonal protecting groups on the amino acid side chains may not be fully removed during this abbreviated cleavage. To obtain full deprotection, a longer 2-h microcleavage using the cleavage cocktail mixture may be performed; however, to just monitor the leucine coupling, full side chain deprotection is not necessary. (viii) After removing the Fmoc on the ε-aminocaproic acid residue, add a solution of 5(6)-TAMRA (52 mg, 120 µmol), PyBOP (63 mg, 120 µmol) and DIPEA (42 µl, 240 µmol) in NMP (7 ml) and shake it overnight at room temperature.
To prevent photobleaching of the fluorophore, wrap the column in aluminum foil. that the crude peptide is of sufficient purity, the next step (Step 1A(xiv-xvi)) may be omitted and the peptide may be used directly in sortase reactions. (xiv) HPLC purification. Dissolve the dried peptide in H 2 O (2 ml) and centrifuge it at 16,873g for 10 min in a tabletop centrifuge to remove particulate matter. Note that up to 50% (vol/vol) tert-butanol may be added to peptides that do not dissolve in pure H 2 O. In addition, spin filters or syringe filters may be used to remove particulate matter. (xv) Purify the centrifuged supernatant by reverse-phase HPLC on a C18 column using a 10-70% buffer B gradient over 15 min, followed by flushing at 90% buffer B for 5 min. We recommend a preliminary small 100-µl injection and adjusting the gradient accordingly for peptide purity and ease of separation. Once a good gradient is established, the remaining crude material may be purified with 400-to 600-µl injections (when using a 1-ml injection loop). (xvi) Analyze the fractions for product by LC/MS and lyophilize the desired fractions to dryness. TAMRA-containing probes consist of a mixture of regioisomers that will probably result in two product peaks during reverse-phase HPLC purification. The different isomers have no effect on labeling.  crItIcal step Verify the identity and purity by LC/MS analysis (linear gradient 5-45% LC/MS buffer B over 10 min) and NMR spectroscopy. In general, NHS ester dyes and probes are more valuable and expensive than the peptide. Therefore, the peptide is used in excess to fully consume the ester. 
3|
Incubate the reactions at room temperature or at 37 °C. Take 1-µl aliquots at 15 min, 1 h, 3 h and 5 h. Add 1× SDS-gel loading buffer to the aliquots and boil them for 2 min. Both room temperature and 37 °C should be tested to see which conditions work best for the protein being labeled. We tend to use a temperature of 37 °C for most reactions.
? trouBlesHootInG  pause poInt After boiling, the aliquots can be flash-frozen and stored at −20 °C until further analysis. To pause the overall reaction, freeze the reaction vial at −20 °C.
4|
Analyze the 1-µl aliquots by SDS-PAGE (10% or 12% (wt/vol) acrylamide for substrates in the 12-80 kDa range) followed by Coomassie staining. Note that some labeled products and starting material proteins have similar molecular masses. A gradient gel of appropriate size and porosity may achieve better separation to properly visualize conversion efficiency 44 .
? trouBlesHootInG purification • tIMInG 1 d 5| Load the sortase reaction into a spin concentrator with an appropriate MWCO and centrifuge it to remove unreacted (low-molecular-weight) probe.
6|
As needed, purify the protein of interest by size-exclusion chromatography using Superdex 75 or 200 resin, depending on its Stokes' radius. Analyze the fractions by SDS-PAGE and/or LC/MS.  crItIcal step If the protein is sufficiently pure at this point, it can be concentrated and is ready for use. ? trouBlesHootInG
7|
If further purification is needed, concentrate the product-containing FPLC fractions with a spin concentrator. Next, purify the product by ion-exchange chromatography (Mono Q or Mono S resin, depending on the charge distribution of the molecule of interest) with a 0-1 M gradient of NaCl.  crItIcal step In those rare instances in which the sortase has properties similar to the product of interest, an initial Ni-NTA affinity chromatography step can be added, as the sortase has a His 6 tag and will bind to the resin. If the protein of interest has a His 6 tag, this added purification will not work and a different affinity tag should be used.
8|
Analyze fractions by SDS-PAGE and/or LC/MS and concentrate the product-containing fractions for use or storage.
? trouBlesHootInG Troubleshooting advice can be found in table 1. Figure 2 | Specific labeling of cholera toxin B subunit (CTxB) at its N terminus with a fluorophore using S. aureus sortase A. (a,b) Coomassiestained gel (a) and its corresponding fluorescent scanning (580 nm emission) (b). TAMRA-LPETGG was synthesized as described in this protocol, and the B subunit of cholera toxin featuring a triglycine at the N terminus was expressed and purified 45 . Upon incubation, S. aureus sortase A forms an acyl intermediate with the TAMRA-labeled peptide, which is resolved by CTxB, resulting in a labeled product. Note that the labeled product is formed only when all three reaction components are mixed together (b) with almost total conversion of CTxB into CTxB-TAMRA (a). The sortase-mediated labeling reaction does not disrupt the natural pentameric conformation of CTxB, which can be detected when the samples loaded onto the SDS-PAGE gel are not boiled. The concentration refers to the CTxB monomer.
